Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

The Liposome Company meets with FDA to discuss Evacet NDA

Feb. 21, 2000

Pierre Fabre designs structurally novel inhibitors of protein prenylation

Feb. 18, 2000

New prostate cancer therapy to be studied in men with no other effective treatment options

Feb. 18, 2000

New series of taxanes designed at BMS

Feb. 18, 2000

Estrogenic activities described for 7alpha-thioestratrienes

Feb. 18, 2000

Purpurinimide photosensitizers with in vivo tumoricidal effects

Feb. 18, 2000

Marine sponges found to produce potent caspase inhibitors

Feb. 17, 2000

Novel vitamin D compounds for cancer, bone disorders

Feb. 17, 2000

MGI Pharma updates irofulven progress during 1999

Feb. 17, 2000

Kyowa Hakko and Geron extend telomerase partnership

Feb. 17, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...